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University Hospital, Taichung Taiwan, ROCA B S T R A C TObjectives: To examine the economic burden of diabetes mellitus
(DM) on medical expenditure among patients with respiratory failure
(RF) requiring mechanical ventilation during hospitalization. Meth-
ods: We extracted the data from Taiwan National Health Research
Insurance Database for those adult patients on their ﬁrst hospital-
ization for RF requiring mechanical ventilation between 2004 and
2010. We examined associations between medical expenditure and
the presence of comorbid DM. We performed independent t tests, chi-
square tests, and multivariate linear regression analysis to identify
factors associated with excess medical expenditure. Results: Of
347,961 patients hospitalized with ﬁrst occurrence of RF requiring
mechanical ventilation, 123,023 (35.36%) patients were documented to
have a previous diagnosis of DM. Patients with RF and DM were sicker
and consumed more health care resources than did patients with RF
without DM. After adjusting for the speciﬁed covariates, mechanicallysee front matter Copyright & 2014, International S
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ondence to: Hsiang-Wen Lin, Graduate Institute
sueh-Shih Road, Taichung, Taiwan 40402, ROC.ventilated patients with RF and DM consumed at least US $618 more
of total inpatient medical expenditure than did patients with RF
without DM. There were statistically signiﬁcant interactions between
age and DM on their total inpatient medical expenditure regardless of
discharge status. Conclusions: DM was associated with more severe
disease status and higher consumption of medical expenditure during
hospitalizations among mechanically ventilated patients due to ﬁrst
occurrence of RF in Taiwan. These ﬁndings provide scientiﬁc evidence
to facilitate appropriate resource allocation and formulate programs
for higher quality of care in the future in Taiwan and other countries.
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respiratory failure.
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Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Mechanical ventilation (MV) in patients with respiratory failure
(RF) is associated with an incremental cost of up to US $1500 per
day in the United States [1,2]. Based on the National Health
Insurance (NHI) report in Taiwan, the cost associated with MV-
dependent patients with RF was approximately US $22,530 per
year [3]. The MV utilization increased by approximately 180%
from 1997 to 2004 in Taiwan [4]. Thus, the greater use of MV
among patients with RF accounts for the large economic burden
on limited resources of the health care system in Taiwan and
other countries.It is estimated that 15% to 25% of the patients with RF
require prolonged MV because of difﬁcult weaning [5,6]. Factors
associated with difﬁcult weaning in patients with RF included
increasing blood urea nitrogen levels and lower comatose
scores [7]. Furthermore, the increasing incidence of MV depend-
ence was associated with the burden of comorbidities [8].
In particular, the increased incidence of MV among younger
patients was associated with a higher burden of obesity,
diabetes, or renal failure [8]. While diabetes mellitus (DM) was
documented to be one of the most frequent complications for
ventilator-dependent patients who were treated at long-term
care hospitals [9], Cheng et al.’s study [4] indicated that DM wasociety for Pharmacoeconomics and Outcomes Research (ISPOR).
conﬂicts of interest with regard to the content of this article.
and School of Pharmacy, College of Pharmacy, China Medical
V A L U E I N H E A L T H R E G I O N A L I S S U E S 3 C ( 2 0 1 4 ) 3 3 – 3 834one of the leading diagnoses among patients with RF
requiring MV.
Patients with DM consumed 4.3 times more health care costs
than did patients without DM, and it accounted for 11.5% of the
total health care cost in Taiwan [10]. Although those critically ill
patients with DM were prone to develop more complications [11],
these diabetic, critically ill patients had equal or even decreased
mortality compared with those without DM [12,13]. As a result,
decreasing mortality among critically ill patients might incur
longer hospitalization and add on more economic burden either
on the perspectives of health care providers and/or the Bureau of
National Health Insurance (BNHI) in Taiwan. The aim of this
study was to examine the economic burden due to DM among
patients with RF requiring MV during hospitalization.Methods
Data Sources
In Taiwan, the BNHI has contracted with 97% of hospitals since 1996
to ensure sufﬁcient access to health care. Currently, the coverage of
both population and hospitals is as high as 99%. The BNHI has
proposed and implemented many strategies to ensure appropriate
use of NHI resources in the hope of controlling the rapid growth of
health care utilization and expenditures. For instance, the Inte-
grated Delivery System (IDS) has encouraged hospitals to set up
respiratory care centers and/or respiratory care wards. These step-
down units provide high-quality, integrated care for patients with
prolonged MV use and help with cost containment. Moreover, those
sicker patients who consume more medical expenditure because of
comorbid diseases and need long-term care (including RF with MV
for 21 days or more) were qualiﬁed to be assigned with the
catastrophic illness certiﬁcate (CIC). The co-payments for these
patients are waived in accordance with NHI policy in Taiwan. Those
patients with RF involved in the IDS programs or assigned with CIC
were also evaluated for their excess medical expenditure.
This study used data from inpatient claims of the National
Health Research Insurance Database, which covered all inpatient
claims of the sampling insured Taiwanese population, during the
study period of 2004 to 2010. The variables that were examined
and evaluated included patients’ demographic characteristics,
disease status (e.g., primary and secondary admission diagnosis),
and health care utilization (e.g., dates of admission and discharge,
IDS, CIC, and hospital expenditure). The components of medical
expenditure included all NHI-covered fees for diagnosis, laboratory
tests, radiography services, therapeutic treatment, surgery, reha-
bilitation, blood products, hemodialysis, special medical supply,
prescribed medications, and other services incurred during hospi-
talization. This study was exempt from the Institutional Review
Board because the National Health Research Insurance Database
contains only de-identiﬁed patient information and is publicly
available through the proper application process.
Study Population
We evaluated beneﬁciaries aged 18 years or older who were
hospitalized because of the ﬁrst occurrence of RF during the years
2004 to 2010 on the NHI inpatient claim data. To minimize
concern for data skewness, we excluded 7100 cases (2%) that
were considered outliers because of extreme inpatient medical
expenditure incurred during hospitalization.
Study Design
We conducted a population-based retrospective data analysis.
For those included beneﬁciaries, the ﬁrst occurrences of RF during
hospitalizations in the years 2004 to 2010 were evaluated. Wedeﬁned those patients with in-patient diagnoses International
Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation codes
of 518.81, 518.82, 518.83, and 518.84 as patients with RF and those
who had the International Classiﬁcation of Diseases, Ninth Revision,
Clinical Modiﬁcation code of 250 as patients with DM. In our study,
all patients with RF, either with DM or without DM, were ever
mechanically ventilated during hospitalizations. We also eval-
uated the disease records regarding their dysfunctional organ
systems during hospitalizations and grouped the systems into six
categories (e.g., circulatory collapse, renal failure, hepatic failure,
and coagulation defects). These categories were adapted from the
results of expert panel discussions and modiﬁed deﬁnitions
obtained from Marshall et al.’s and Gall et al.’s studies [14,15].
Those beneﬁciaries who lived in areas belonging to the ﬁrst and
fourth quartiles of population density in Taiwan were grouped into
low and high urbanization, respectively. We used Charlson’s comor-
bidity index to estimate disease burden and as a controlling variable
for potential confounding [16]. We summed all claimed reimburse-
ment expenditures that were associated with RF for total hospital
expenditure during hospitalizations. We calculated the durations
between admission and discharge dates during hospitalization as
“length of stay (LOS)” and categorized the LOS into three levels. The
medical expenditures were expressed in US dollars (US $1 ¼ 31.64
New Taiwan Dollar in 2010). All the aforementioned variables were
assumed to be related to medical expenditure that occurred in
hospitals.
Speciﬁcally, discharge status in the NHRID was categorized as
“recovered,” “transferred to outpatients care,” “deceased,”
“against-advice discharge,” “critical against-advice discharge,”
“transferred to another hospital,” and others. In Taiwan, the
majority of citizens prefer to receive end-of-life care at home and
so hospitals usually allow patients to be discharged under critical
condition on the request of the patients’ family. Therefore, we
classiﬁed discharge status into two groups: alive and dead
(including critical against-advice discharge).
Statistical Analysis
We used independent t tests and chi-square tests to analyze
patients’ sociodemographic characteristics, disease characteris-
tics, their health utilization, and corresponding hospital character-
istics among patients with ﬁrst occurred RF with DM and without
DM during hospitalization. As for the medical expenditure, it is
expected to have some extreme values. Therefore, the truncated
mean and the corresponding simple andmultiple linear regression
models were performed to assess the excess medical expenditure
between patients with RF and DM and patients with RF without
DM, stratiﬁed by their death status, after excluding 2% of the cases.
Sensitivity analyses to include all cases were performed to conﬁrm
the robustness of all ﬁndings. The aforementioned variables of
interest, including patients’ characteristics, disease status, hospi-
tal settings, involvement of catastrophic illness status, and/or IDS,
were expected to correlate with the consumption of medical
expenditure through the consensus of focus group discussions.
Thus, these variables were taken into account into different
models when performing multiple regression analyses. Further-
more, the interaction effects of total hospital expenditure with age
and DM were examined. The statistical signiﬁcance level was set
at a two-sided P value of less than 0.05. All analyses used the SAS
software version 9.3 (SAS Institute, Inc., Cary, NC).
Results
Patient Characteristics
For the study period 2004 to 2010, the inpatient claims for 347,961
patients with RF were retrieved for further analyses. There were
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nosis of DM. The incidence of RF during hospitalization occurred
mostly in persons aged 60 years or more. Patients with RF who
had DM were more commonly men, had more comorbidities, and
more dysfunctional organ systems than did those without DM
(Table 1). Patients with RF and DM used more health care
resources, hold CIC, had involvement in IDS programs, and were
sicker (higher prevalence of various organ dysfunction) than did
patients with RF without DM (Table 2).
Total Medical Expenditure during Hospitalizations
Regardless of being alive or dead on discharge, patients with RF
and DM consumed signiﬁcantly higher mean medical expendi-
ture than did patients with RF but without DM . After adjusting
for age, sex, hospital scale, urbanization of hospitals, number of
comorbidities, and LOS (model 1), patients with RF and DM had
signiﬁcantly higher total medical expenditure (extra $1119 and
$1469, respectively) than did their corresponding counterparts
(Table 3). After the adjustment of aforementioned covariates in
model 1 and those variables of CIC and dysfunctional organ
systems, it was found that patients with RF and DM consumed
more money (extra $682 for alive and extra $618 for dead) than
did patients with RF without DM (in model 4). Compared with the
adjustment of holding the CIC (model 1 vs. model 3 and model 2
vs. model 4), involvement in IDS programs was not associated
with changes in medical expenditure among patients with RF and
DM or patients with RF without DM. After additional adjustment
of holding the CIC, models 3 and 4 explained more additional
variance of total medical expenditure than did models 1 and 2,
respectively. Patients with RF and DM who did not survive had
higher medical expenditures than did those who were alive at
discharge. The ﬁndings were opposed after controlling for hold-
ing the CIC.
After adjusting for the holding of CIC, age, sex, hospital
level, urbanization, number of comorbidities, LOS, and the
existence of dysfunction organ systems, all groups had the
highest total medical expenditure at the age of 18 to 29 years
(Fig. 1). Alive patients with RF without DM had decreasing
medical expenditure as age increased. Dead patients with RF
without DM had a similar trend before the age of 50 to 59 years,
but the expenditure increases with aging again after the age of
80 years, but at a slightly reduced rate. There were signiﬁcantTable 1 – Comparisons in demographic and disease char
with and without DM (2004–2010).
Variable Res
Non-DM (n ¼ 224,938)
Age (y)
18–29 6,064 (2.7)
30–39 9,541 (4.2)
40–49 18,411 (8.2)
50–59 24,406 (10.9)
60–69 29,745 (13.2)
70–79 59,837 (26.6)
Z80 76,934 (34.2)
Sex
Female 78,528 (34.9)
Male 146,363 (65.1)
No. of comorbidities 0.9  1.0
No. of organ/systems dysfunction* 2.2  2.7
DM, diabetes mellitus.
* Missing values include 57 persons for the category sex, 2 in hospital levinteractions between age and DM, regardless of discharge
status (Pso 0.001).
Furthermore, ﬁndings of sensitivity analysis regarding distri-
butions of patient characteristics and effects of DM and alive
status on total medical expenditure during hospitalization by
including all cases were similar to those obtained from excluding
cases in the extreme 2%. The regression analysis ﬁndings were
exactly the same.Discussion
This study shows that mechanically ventilated patients with RF
and DM had greater comorbidity, dysfunctional organs/systems,
and consumed more health care resources than did patients with
RF without DM. After adjusting for the corresponding covariates,
it was found that patients with RF and DM consumed more total
inpatient medical expenditure, regardless of discharge status,
than did patients with RF without DM. The holding of CIC was
associated with more consumption of total medical expenditure
among either dead or alive patients with RF and DM.
The prevalence of DM in Taiwan has increased to 9.2% [17].
The corresponding medical expenditure for DM accounted for
4.5% of all outpatient expenditure of the NHI and 1.1% of
hospitalization expenditure in 2008 [18]. Patients with DM had
higher mortality than did the general population, especially
among males [19]. While DM was documented to be one of the
most common comorbidities among patients with long-term MV
[9], this study demonstrated that patients with RF and DM were
sicker, used more health resources, and consumed more total
medical expenditure than did patients with RF without DM. This
was consistent with evidence from the literature [4,10] but did
not correspond with the evidence found in septic patients with
DM who developed acute RF [20].
Furthermore, dead patients with RF and DM consumed an
additional US $618 in medical expenditure during hospital-
izations than did those without DM after multivariate adjust-
ments. This additional inpatient expenditure for patients with
RF and DM represents approximately 61% of total expenditure
on health care per capita in 2007 in Taiwan (= US $618/1050,
where US $618 was the additional medical expenditure during
hospitalization for dead patients with RF and DM in Taiwan)
[20], and 20% of the total cost of willing to pay to cure DM peracteristics between patients with respiratory failure
piratory failure, n (%) P
DM (n ¼ 123,023) Total (N ¼ 347,961)
o0.001
277 (0.2) 6,341 (1.8)
1,231 (1.0) 10,772 (3.1)
5,076 (4.1) 23,487 (6.7)
12,589 (10.2) 36,995 (10.6)
22,635 (18.4) 52,380 (15.1)
42,553 (34.6) 102,390 (29.4)
38,662 (31.4) 115,596 (33.2)
o0.001
55,297 (44.9) 133,825 (38.5)
67,716 (55.1) 214,079 (61.5)
1.4  1.2 1.1  1.1 o0.001
2.6  2.8 2.3  2.7 o0.001
el, and 2 in urbanization. Some values are presented as mean  SD.
Table 2 – Comparisons in health utilization and disease statuses between patients with respiratory failure with
and without DM.
Variables Non-DM (n ¼ 224,937),
n (%)
DM (n ¼ 123,0220),
n (%)
P
Existence of dysfunctional organ system
Circulatory collapse 103,948 (46.2) 64,201 (52.2) o0.001
Renal failure 87,736 (39.0) 56,712 (46.1) o0.001
Hepatic failure 74,339 (33.1) 49,699 (40.4) o0.001
Coagulation defects 74,733 (33.2) 49,780 (40.5) o0.001
Central nervous system failure 75,099 (33.4) 50,127 (40.8) o0.001
Acidosis 75,596 (33.6) 50,481 (41.0) o0.001
Length of stay (d) 39.0  82.3 48.2  81.9 o0.001
Length of stay categorized into three levels o0.001
Short (r7 d) 57,695 (25.6) 24,293 (19.7)
Intermediate (8–21 d) 65,367 (29.1) 33,698 (27.4)
Long (421 d) 101,876 (45.3) 65,032 (52.9)
Holding catastrophic illness card during hospitalization 44,578 (19.8) 33,464 (27.2) o0.001
Involved in Integrated Delivery System (IDS) during hospitalization 17,791 (7.9) 13,739 (11.2) o0.001
Type of corresponding hospitals o0.001
Medical center 84,532 (37.6) 39,947 (32.5)
Regional hospital 96,155 (42.7) 54,316 (44.1)
District hospital 44,250 (29.7) 28,759 (23.4)
Urbanization of hospitals o0.001
Low 16,899 (7.5) 9,365 (7.6)
Moderate 44,812 (19.9) 23,717 (19.3)
High 163,226 (72.6) 89,940 (73.1)
DM, diabetes mellitus.
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expenses used to manage every two patients with RF and DM
compared with patients with RF without DM during hospital-
izations in Taiwan could be better utilized to treat other
conditions in Taiwan as in the other countries (i.e., Medicare
patients’ receiving surgical care due to peripheral arterial
disease in the United States [US $1450  106]) [22]. Other studies
have demonstrated that patients with DM, who were older, had
cardiovascular disease, neuropathy, or heart failure contributedTable 3 – Multiple linear regression analysis for compari
patients with and without DM, stratiﬁed by outcomes on
DM Alive
Coefﬁcient  SE Adjusted
Unadjusted 2297  64 0.01
Model 1 1119  55 0.33
Model 2 822  51 0.41
Model 3* 855  51 0.42
Model 4† 682  48 0.47
Notes. Model 1: adjusted for age, sex, hospital level, urbanization, numbe
Model 2: adjusted for covariates in model 1 plus circulatory collapse, ren
nervous system failure.
Model 3: adjusted for age, sex, hospital level, urbanization, number of com
plus catastrophic illness card).
Model 4: adjusted for covariates in model 3 plus circulatory collapse, ren
nervous system failure (model 2 plus catastrophic illness card).
DM, diabetes mellitus; IDS, Integrated Delivery System; SE, standard err
* The cost coefﬁcients as for the alive and dead patients reduced to US $8
for IDS.
† The cost coefﬁcients as for the alive and dead patients reduced to US
adjusted for IDS.to more diabetic and non–diabetic-related medical expenditure
and deaths [19,23,24]. Therefore, such profound economic
burden warrants increased effort to improve current diabetic
care programs designed to prevent patients with DM from
disease progression or hospitalization.
Patients hospitalized with RF commonly require MV and
usually receive a complex and technically sophisticated level of
care. In Taiwan, IDS programs provide high quality of integrated
care for patients with prolonged MV use to ensure cost-effectiveson in total medical expenditure (US $) between
discharge.
Dead
R2 Coefﬁcient  SE Adjusted R2
2798  90 0.01
1469  74 0.38
1087  70 0.45
710  64 0.54
618  63 0.55
r of comorbidities, and length of hospital stay.
al failure, hepatic failure, coagulation defects, acidosis, and central
orbidities and length of stay, and catastrophic illness card (model 1
al failure, hepatic failure, coagulation defects, acidosis, and central
or.
31  50 and US $701  64, respectively, after these were also adjusted
$ 662  48 and US $ 614  63, respectively, after these were also
Fig. 1 – Comparison of total medical expenditure (US $)
among patients with respiratory failure with and without
DM after adjustments, stratiﬁed by status on discharge. Note.
The adjustment covariates included age, sex, hospital level,
urbanization, number of comorbidities, length of hospital
stay, existence of dysfunction systems, and holding the
catastrophic illness card. DM, diabetes mellitus.
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ventilator-dependent patients are allowed to stay up to 21 days
in intensive care units and up to 42 days in respiratory care
centers as per the health policy restriction in the IDS program.
The implementation of IDS programs for patients with RF in
Taiwan was successful [7], similar to programs developed in Italy
[26]. Our results, however, showed more economic impact of
holding CIC on the medical expenditure among patients with RF
and DM during hospitalization, while the IDS program had a
negligible impact on the inpatient medical expenditure. These
ﬁndings corresponded with the phenomena that the BNHI had
higher reimbursement rates for patients with CIC than did
patients involved in IDS programs because these patients had
greater disease severity and required more intensive care.
Although the NHI plays a stabilizing role in the society in
Taiwan, the increasing incidence of catastrophic illnesses and RF
would result in not only economic burden but also society burden
while the population is aging. In 2008, there were 19,246 patients
with CIC held due to long-term MV, representing the third leading
cost for total medical expenditure and the second per capita cost
among patients with CIC [18]. The claimed reimbursement of
medical expenditure among patients with listed catastrophic
illnesses (3.17% of all insurers) accounted for one fourth of all
NHI expenditure [3]. Similar to other health care systems
throughout the world, the issues of controlling costs, allocating
available resources, enhancing the quality of care, improving
beneﬁciaries’ health, and ensuring equity of medical access for
sicker patients and others in Taiwan remain.
Nevertheless, this study has some limitations. This study did
not include outpatients and nonhospital costs, in terms of indirect
cost, or other out-of-pocket co-payments. It is important to include
these costs for evaluating the overall economic burden of RF due to
DM even if the trend of impacts would not change signiﬁcantly.
This study focused on only those beneﬁciaries with their ﬁrst
occurrences of RF during hospitalizations in the years 2004 to 2010.
In other words, those who had repeated visits to hospitals due to
RF were excluded from further analysis. Thus, this study is
applicable to only patients with DM or without DM during their
ﬁrst occurrence of RF in hospitals. From the NHI perspective, such
patients with RF were considered very ill and are reimbursed for
most of their medical expenditure because they need more
intensive medical care in hospitals. As such, their outpatient
expenditure was not the major concern when managing their RF.
Furthermore, the lack of laboratory data and severity scores (e.g.,the Acute Physiology and Chronic Health Evaluation II) and the use
of diagnostic practice by the International Classiﬁcation of Diseases,
Ninth Revision, Clinical Modiﬁcation codes may not reﬂect the disease
severity. The detailed data on the utilization of MV were not
included. The variability in respiratory care models in different
medical settings might be the issue. The holding of CIC and
involvement in IDS programs for each patient, however, would be
key elements to ensure similarity of care models.
With the large sample size in this study, the statistically
signiﬁcant results might be due to the occurrence of type I error.
Thus, the extent and scale of each variable or coefﬁcient would be
more beneﬁcial to be interpreted but not the signiﬁcant levels.
Last, the distribution of medical expenditure was still skewed
to the right after removing 2% of cases and the corresponding
testing of normality (one sample Kolmogorov-Smirnov) was
rejected (P o 0.05). The sensitivity analyses to include all cases
for all ﬁndings did not change the results at all. Although the
excess medical expenditure during hospitalization was the major
concern from NHI and providers’ perspectives in this study, we
performed multivariate regression analyses after excluding 2% of
extreme values. Using generalized linear model of log-transformed
approach, as Morales et al. [27] and Pasquale et al. [28] did, solves
the problems of having skewed data of cost. The interpretation of
the exponentiated coefﬁcient β for diabetes status is the ratio of
the expected geometric mean of costs for patients with DM over
the expected geometric mean for patients without DM. Different
analysis methods, including generalized linear model, ordinary
least squares using linear regression, median quantile regression,
Winsorizing, or propensity score case matching, would either
overestimate or underestimate the extrapolated cost on adjusting
for the key variable or not [29]. There was no conclusion, however,
on which approach is better off. The goodness of ﬁt for data using
ordinary least squares linear regression might not be perfect. The
interpretation of mean medical expenditure, however, might be
easier than the relative value of cost after transforming it back to
exponential value from log values. Speciﬁcally, the value of
medical expenditure is understood by clinicians and general
health policy makers who have no economic background as in
the other population study to describe the determinants of health
care expenditure and associated factors in Korea [30]. Ideally,
further analyses using more appropriate approaches might be
needed to verify the results in this study.Conclusions
The presence of DM as a comorbidity signiﬁcantly affects disease
status and increases hospital medical expenditures among
mechanically ventilated patients due to the ﬁrst occurrence of
RF in hospitals. It is beneﬁcial to understand the extent of
economic burden of DM and its impact on mechanically venti-
lated patients due to RF in Taiwan. This information can be used
to help develop and implement sound public health strategies for
programs aimed at improving DM management and reducing the
large health care burden in Taiwan in the future.Acknowledgments
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